nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—pancreatic cancer	0.325	1	CbGaD
Etodolac—UGT1A9—Irinotecan—pancreatic cancer	0.127	0.303	CbGbCtD
Etodolac—UGT2B7—Epirubicin—pancreatic cancer	0.123	0.295	CbGbCtD
Etodolac—ALB—Erlotinib—pancreatic cancer	0.0436	0.104	CbGbCtD
Etodolac—ALB—Irinotecan—pancreatic cancer	0.0393	0.0939	CbGbCtD
Etodolac—ALB—Fluorouracil—pancreatic cancer	0.0377	0.0901	CbGbCtD
Etodolac—CYP2C9—Tamoxifen—pancreatic cancer	0.0276	0.0659	CbGbCtD
Etodolac—CYP2C9—Fluorouracil—pancreatic cancer	0.0203	0.0486	CbGbCtD
Etodolac—Bronchitis—Epirubicin—pancreatic cancer	0.000165	0.000769	CcSEcCtD
Etodolac—Anaemia—Docetaxel—pancreatic cancer	0.000164	0.000763	CcSEcCtD
Etodolac—Pancytopenia—Epirubicin—pancreatic cancer	0.000163	0.000759	CcSEcCtD
Etodolac—Gastritis—Doxorubicin—pancreatic cancer	0.000163	0.000758	CcSEcCtD
Etodolac—Vomiting—Sunitinib—pancreatic cancer	0.000162	0.000753	CcSEcCtD
Etodolac—Body temperature increased—Gemcitabine—pancreatic cancer	0.000161	0.000751	CcSEcCtD
Etodolac—Dysuria—Epirubicin—pancreatic cancer	0.000161	0.000748	CcSEcCtD
Etodolac—Neutropenia—Epirubicin—pancreatic cancer	0.000161	0.000748	CcSEcCtD
Etodolac—Rash—Sunitinib—pancreatic cancer	0.00016	0.000746	CcSEcCtD
Etodolac—Dermatitis—Sunitinib—pancreatic cancer	0.00016	0.000746	CcSEcCtD
Etodolac—Abdominal distension—Doxorubicin—pancreatic cancer	0.00016	0.000745	CcSEcCtD
Etodolac—Urticaria—Fluorouracil—pancreatic cancer	0.000159	0.000742	CcSEcCtD
Etodolac—Headache—Sunitinib—pancreatic cancer	0.000159	0.000742	CcSEcCtD
Etodolac—Syncope—Docetaxel—pancreatic cancer	0.000159	0.000741	CcSEcCtD
Etodolac—Asthma—Doxorubicin—pancreatic cancer	0.000159	0.00074	CcSEcCtD
Etodolac—Leukopenia—Docetaxel—pancreatic cancer	0.000159	0.000739	CcSEcCtD
Etodolac—Pollakiuria—Epirubicin—pancreatic cancer	0.000159	0.000739	CcSEcCtD
Etodolac—Body temperature increased—Fluorouracil—pancreatic cancer	0.000159	0.000738	CcSEcCtD
Etodolac—Eosinophilia—Doxorubicin—pancreatic cancer	0.000157	0.000732	CcSEcCtD
Etodolac—Palpitations—Docetaxel—pancreatic cancer	0.000157	0.00073	CcSEcCtD
Etodolac—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000157	0.00073	CcSEcCtD
Etodolac—Loss of consciousness—Docetaxel—pancreatic cancer	0.000156	0.000726	CcSEcCtD
Etodolac—Pancreatitis—Doxorubicin—pancreatic cancer	0.000156	0.000725	CcSEcCtD
Etodolac—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000155	0.000721	CcSEcCtD
Etodolac—Hypersensitivity—Irinotecan—pancreatic cancer	0.000154	0.000718	CcSEcCtD
Etodolac—Pneumonia—Epirubicin—pancreatic cancer	0.000154	0.000717	CcSEcCtD
Etodolac—Convulsion—Docetaxel—pancreatic cancer	0.000154	0.000716	CcSEcCtD
Etodolac—Hypertension—Docetaxel—pancreatic cancer	0.000153	0.000713	CcSEcCtD
Etodolac—Bronchitis—Doxorubicin—pancreatic cancer	0.000153	0.000711	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000152	0.000707	CcSEcCtD
Etodolac—Myalgia—Docetaxel—pancreatic cancer	0.000151	0.000703	CcSEcCtD
Etodolac—Arthralgia—Docetaxel—pancreatic cancer	0.000151	0.000703	CcSEcCtD
Etodolac—Nausea—Sunitinib—pancreatic cancer	0.000151	0.000703	CcSEcCtD
Etodolac—Pancytopenia—Doxorubicin—pancreatic cancer	0.000151	0.000703	CcSEcCtD
Etodolac—Renal failure—Epirubicin—pancreatic cancer	0.000151	0.000701	CcSEcCtD
Etodolac—Asthenia—Irinotecan—pancreatic cancer	0.00015	0.0007	CcSEcCtD
Etodolac—Jaundice—Epirubicin—pancreatic cancer	0.000149	0.000695	CcSEcCtD
Etodolac—Stomatitis—Epirubicin—pancreatic cancer	0.000149	0.000695	CcSEcCtD
Etodolac—Conjunctivitis—Epirubicin—pancreatic cancer	0.000149	0.000693	CcSEcCtD
Etodolac—Dysuria—Doxorubicin—pancreatic cancer	0.000149	0.000692	CcSEcCtD
Etodolac—Neutropenia—Doxorubicin—pancreatic cancer	0.000149	0.000692	CcSEcCtD
Etodolac—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000148	0.000688	CcSEcCtD
Etodolac—Dry mouth—Docetaxel—pancreatic cancer	0.000148	0.000688	CcSEcCtD
Etodolac—Sweating—Epirubicin—pancreatic cancer	0.000147	0.000683	CcSEcCtD
Etodolac—Pollakiuria—Doxorubicin—pancreatic cancer	0.000147	0.000683	CcSEcCtD
Etodolac—Asthenia—Gemcitabine—pancreatic cancer	0.000146	0.000682	CcSEcCtD
Etodolac—Haematuria—Epirubicin—pancreatic cancer	0.000146	0.00068	CcSEcCtD
Etodolac—Confusional state—Docetaxel—pancreatic cancer	0.000146	0.00068	CcSEcCtD
Etodolac—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000145	0.000675	CcSEcCtD
Etodolac—Oedema—Docetaxel—pancreatic cancer	0.000145	0.000674	CcSEcCtD
Etodolac—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000145	0.000674	CcSEcCtD
Etodolac—Pruritus—Gemcitabine—pancreatic cancer	0.000144	0.000672	CcSEcCtD
Etodolac—Infection—Docetaxel—pancreatic cancer	0.000144	0.00067	CcSEcCtD
Etodolac—Sinusitis—Epirubicin—pancreatic cancer	0.000144	0.000669	CcSEcCtD
Etodolac—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000143	0.000667	CcSEcCtD
Etodolac—Diarrhoea—Irinotecan—pancreatic cancer	0.000143	0.000667	CcSEcCtD
Etodolac—Agranulocytosis—Epirubicin—pancreatic cancer	0.000143	0.000665	CcSEcCtD
Etodolac—Pneumonia—Doxorubicin—pancreatic cancer	0.000143	0.000663	CcSEcCtD
Etodolac—Shock—Docetaxel—pancreatic cancer	0.000143	0.000663	CcSEcCtD
Etodolac—Pruritus—Fluorouracil—pancreatic cancer	0.000142	0.000661	CcSEcCtD
Etodolac—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000142	0.00066	CcSEcCtD
Etodolac—Tachycardia—Docetaxel—pancreatic cancer	0.000141	0.000658	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000141	0.000654	CcSEcCtD
Etodolac—Diarrhoea—Gemcitabine—pancreatic cancer	0.00014	0.00065	CcSEcCtD
Etodolac—Renal failure—Doxorubicin—pancreatic cancer	0.000139	0.000648	CcSEcCtD
Etodolac—Dizziness—Irinotecan—pancreatic cancer	0.000139	0.000645	CcSEcCtD
Etodolac—Haemoglobin—Epirubicin—pancreatic cancer	0.000138	0.000643	CcSEcCtD
Etodolac—Stomatitis—Doxorubicin—pancreatic cancer	0.000138	0.000643	CcSEcCtD
Etodolac—Jaundice—Doxorubicin—pancreatic cancer	0.000138	0.000643	CcSEcCtD
Etodolac—Anorexia—Docetaxel—pancreatic cancer	0.000138	0.000643	CcSEcCtD
Etodolac—Rhinitis—Epirubicin—pancreatic cancer	0.000138	0.000642	CcSEcCtD
Etodolac—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000138	0.000641	CcSEcCtD
Etodolac—Haemorrhage—Epirubicin—pancreatic cancer	0.000138	0.00064	CcSEcCtD
Etodolac—Hepatitis—Epirubicin—pancreatic cancer	0.000138	0.00064	CcSEcCtD
Etodolac—Diarrhoea—Fluorouracil—pancreatic cancer	0.000137	0.000639	CcSEcCtD
Etodolac—Pharyngitis—Epirubicin—pancreatic cancer	0.000137	0.000635	CcSEcCtD
Etodolac—Sweating—Doxorubicin—pancreatic cancer	0.000136	0.000632	CcSEcCtD
Etodolac—Hypotension—Docetaxel—pancreatic cancer	0.000135	0.00063	CcSEcCtD
Etodolac—Haematuria—Doxorubicin—pancreatic cancer	0.000135	0.000629	CcSEcCtD
Etodolac—Vomiting—Irinotecan—pancreatic cancer	0.000133	0.00062	CcSEcCtD
Etodolac—Sinusitis—Doxorubicin—pancreatic cancer	0.000133	0.000619	CcSEcCtD
Etodolac—Dizziness—Fluorouracil—pancreatic cancer	0.000133	0.000618	CcSEcCtD
Etodolac—Visual impairment—Epirubicin—pancreatic cancer	0.000133	0.000617	CcSEcCtD
Etodolac—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000132	0.000616	CcSEcCtD
Etodolac—Rash—Irinotecan—pancreatic cancer	0.000132	0.000615	CcSEcCtD
Etodolac—Dermatitis—Irinotecan—pancreatic cancer	0.000132	0.000614	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000132	0.000614	CcSEcCtD
Etodolac—Headache—Irinotecan—pancreatic cancer	0.000131	0.000611	CcSEcCtD
Etodolac—Insomnia—Docetaxel—pancreatic cancer	0.000131	0.00061	CcSEcCtD
Etodolac—Paraesthesia—Docetaxel—pancreatic cancer	0.00013	0.000605	CcSEcCtD
Etodolac—Erythema multiforme—Epirubicin—pancreatic cancer	0.00013	0.000605	CcSEcCtD
Etodolac—Vomiting—Gemcitabine—pancreatic cancer	0.00013	0.000604	CcSEcCtD
Etodolac—Dyspnoea—Docetaxel—pancreatic cancer	0.000129	0.000601	CcSEcCtD
Etodolac—Somnolence—Docetaxel—pancreatic cancer	0.000129	0.000599	CcSEcCtD
Etodolac—Rash—Gemcitabine—pancreatic cancer	0.000129	0.000599	CcSEcCtD
Etodolac—Dermatitis—Gemcitabine—pancreatic cancer	0.000129	0.000598	CcSEcCtD
Etodolac—Tinnitus—Epirubicin—pancreatic cancer	0.000128	0.000597	CcSEcCtD
Etodolac—Haemoglobin—Doxorubicin—pancreatic cancer	0.000128	0.000595	CcSEcCtD
Etodolac—Headache—Gemcitabine—pancreatic cancer	0.000128	0.000595	CcSEcCtD
Etodolac—Flushing—Epirubicin—pancreatic cancer	0.000128	0.000594	CcSEcCtD
Etodolac—Vomiting—Fluorouracil—pancreatic cancer	0.000128	0.000594	CcSEcCtD
Etodolac—Rhinitis—Doxorubicin—pancreatic cancer	0.000128	0.000594	CcSEcCtD
Etodolac—Dyspepsia—Docetaxel—pancreatic cancer	0.000128	0.000593	CcSEcCtD
Etodolac—Haemorrhage—Doxorubicin—pancreatic cancer	0.000127	0.000592	CcSEcCtD
Etodolac—Hepatitis—Doxorubicin—pancreatic cancer	0.000127	0.000592	CcSEcCtD
Etodolac—Rash—Fluorouracil—pancreatic cancer	0.000127	0.000589	CcSEcCtD
Etodolac—Dermatitis—Fluorouracil—pancreatic cancer	0.000126	0.000588	CcSEcCtD
Etodolac—Pharyngitis—Doxorubicin—pancreatic cancer	0.000126	0.000588	CcSEcCtD
Etodolac—Decreased appetite—Docetaxel—pancreatic cancer	0.000126	0.000586	CcSEcCtD
Etodolac—Headache—Fluorouracil—pancreatic cancer	0.000126	0.000585	CcSEcCtD
Etodolac—Fatigue—Docetaxel—pancreatic cancer	0.000125	0.000581	CcSEcCtD
Etodolac—Nausea—Irinotecan—pancreatic cancer	0.000124	0.000579	CcSEcCtD
Etodolac—Pain—Docetaxel—pancreatic cancer	0.000124	0.000576	CcSEcCtD
Etodolac—Constipation—Docetaxel—pancreatic cancer	0.000124	0.000576	CcSEcCtD
Etodolac—Chills—Epirubicin—pancreatic cancer	0.000123	0.000574	CcSEcCtD
Etodolac—Arrhythmia—Epirubicin—pancreatic cancer	0.000123	0.000572	CcSEcCtD
Etodolac—Visual impairment—Doxorubicin—pancreatic cancer	0.000123	0.000571	CcSEcCtD
Etodolac—Alopecia—Epirubicin—pancreatic cancer	0.000122	0.000566	CcSEcCtD
Etodolac—Nausea—Gemcitabine—pancreatic cancer	0.000121	0.000564	CcSEcCtD
Etodolac—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00012	0.00056	CcSEcCtD
Etodolac—Feeling abnormal—Docetaxel—pancreatic cancer	0.000119	0.000555	CcSEcCtD
Etodolac—Nausea—Fluorouracil—pancreatic cancer	0.000119	0.000555	CcSEcCtD
Etodolac—Tinnitus—Doxorubicin—pancreatic cancer	0.000119	0.000552	CcSEcCtD
Etodolac—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000118	0.000551	CcSEcCtD
Etodolac—Flushing—Doxorubicin—pancreatic cancer	0.000118	0.00055	CcSEcCtD
Etodolac—Flatulence—Epirubicin—pancreatic cancer	0.000118	0.000549	CcSEcCtD
Etodolac—Tension—Epirubicin—pancreatic cancer	0.000117	0.000547	CcSEcCtD
Etodolac—Dysgeusia—Epirubicin—pancreatic cancer	0.000117	0.000546	CcSEcCtD
Etodolac—Nervousness—Epirubicin—pancreatic cancer	0.000116	0.000541	CcSEcCtD
Etodolac—Abdominal pain—Docetaxel—pancreatic cancer	0.000115	0.000533	CcSEcCtD
Etodolac—Body temperature increased—Docetaxel—pancreatic cancer	0.000115	0.000533	CcSEcCtD
Etodolac—Chills—Doxorubicin—pancreatic cancer	0.000114	0.000531	CcSEcCtD
Etodolac—Arrhythmia—Doxorubicin—pancreatic cancer	0.000114	0.000529	CcSEcCtD
Etodolac—Vision blurred—Epirubicin—pancreatic cancer	0.000113	0.000525	CcSEcCtD
Etodolac—Alopecia—Doxorubicin—pancreatic cancer	0.000112	0.000523	CcSEcCtD
Etodolac—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000111	0.000517	CcSEcCtD
Etodolac—Anaemia—Epirubicin—pancreatic cancer	0.000111	0.000515	CcSEcCtD
Etodolac—Flatulence—Doxorubicin—pancreatic cancer	0.000109	0.000508	CcSEcCtD
Etodolac—Tension—Doxorubicin—pancreatic cancer	0.000109	0.000506	CcSEcCtD
Etodolac—Dysgeusia—Doxorubicin—pancreatic cancer	0.000108	0.000505	CcSEcCtD
Etodolac—Malaise—Epirubicin—pancreatic cancer	0.000108	0.000502	CcSEcCtD
Etodolac—Nervousness—Doxorubicin—pancreatic cancer	0.000108	0.000501	CcSEcCtD
Etodolac—Vertigo—Epirubicin—pancreatic cancer	0.000108	0.000501	CcSEcCtD
Etodolac—Syncope—Epirubicin—pancreatic cancer	0.000107	0.0005	CcSEcCtD
Etodolac—Leukopenia—Epirubicin—pancreatic cancer	0.000107	0.000499	CcSEcCtD
Etodolac—Hypersensitivity—Docetaxel—pancreatic cancer	0.000107	0.000497	CcSEcCtD
Etodolac—Palpitations—Epirubicin—pancreatic cancer	0.000106	0.000492	CcSEcCtD
Etodolac—Loss of consciousness—Epirubicin—pancreatic cancer	0.000105	0.00049	CcSEcCtD
Etodolac—Vision blurred—Doxorubicin—pancreatic cancer	0.000104	0.000486	CcSEcCtD
Etodolac—Asthenia—Docetaxel—pancreatic cancer	0.000104	0.000484	CcSEcCtD
Etodolac—Convulsion—Epirubicin—pancreatic cancer	0.000104	0.000483	CcSEcCtD
Etodolac—Hypertension—Epirubicin—pancreatic cancer	0.000103	0.000481	CcSEcCtD
Etodolac—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000103	0.000478	CcSEcCtD
Etodolac—Pruritus—Docetaxel—pancreatic cancer	0.000102	0.000477	CcSEcCtD
Etodolac—Anaemia—Doxorubicin—pancreatic cancer	0.000102	0.000476	CcSEcCtD
Etodolac—Myalgia—Epirubicin—pancreatic cancer	0.000102	0.000474	CcSEcCtD
Etodolac—Arthralgia—Epirubicin—pancreatic cancer	0.000102	0.000474	CcSEcCtD
Etodolac—Anxiety—Epirubicin—pancreatic cancer	0.000102	0.000473	CcSEcCtD
Etodolac—Discomfort—Epirubicin—pancreatic cancer	0.000101	0.000469	CcSEcCtD
Etodolac—Malaise—Doxorubicin—pancreatic cancer	9.99e-05	0.000465	CcSEcCtD
Etodolac—Dry mouth—Epirubicin—pancreatic cancer	9.97e-05	0.000464	CcSEcCtD
Etodolac—Vertigo—Doxorubicin—pancreatic cancer	9.95e-05	0.000463	CcSEcCtD
Etodolac—Syncope—Doxorubicin—pancreatic cancer	9.93e-05	0.000462	CcSEcCtD
Etodolac—Leukopenia—Doxorubicin—pancreatic cancer	9.92e-05	0.000461	CcSEcCtD
Etodolac—Diarrhoea—Docetaxel—pancreatic cancer	9.91e-05	0.000461	CcSEcCtD
Etodolac—Confusional state—Epirubicin—pancreatic cancer	9.85e-05	0.000458	CcSEcCtD
Etodolac—Palpitations—Doxorubicin—pancreatic cancer	9.79e-05	0.000456	CcSEcCtD
Etodolac—Anaphylactic shock—Epirubicin—pancreatic cancer	9.77e-05	0.000455	CcSEcCtD
Etodolac—Oedema—Epirubicin—pancreatic cancer	9.77e-05	0.000455	CcSEcCtD
Etodolac—Loss of consciousness—Doxorubicin—pancreatic cancer	9.74e-05	0.000453	CcSEcCtD
Etodolac—Infection—Epirubicin—pancreatic cancer	9.71e-05	0.000452	CcSEcCtD
Etodolac—Shock—Epirubicin—pancreatic cancer	9.61e-05	0.000447	CcSEcCtD
Etodolac—Convulsion—Doxorubicin—pancreatic cancer	9.6e-05	0.000447	CcSEcCtD
Etodolac—Dizziness—Docetaxel—pancreatic cancer	9.58e-05	0.000446	CcSEcCtD
Etodolac—Thrombocytopenia—Epirubicin—pancreatic cancer	9.57e-05	0.000445	CcSEcCtD
Etodolac—Hypertension—Doxorubicin—pancreatic cancer	9.56e-05	0.000445	CcSEcCtD
Etodolac—Tachycardia—Epirubicin—pancreatic cancer	9.54e-05	0.000444	CcSEcCtD
Etodolac—Hyperhidrosis—Epirubicin—pancreatic cancer	9.45e-05	0.00044	CcSEcCtD
Etodolac—Arthralgia—Doxorubicin—pancreatic cancer	9.43e-05	0.000439	CcSEcCtD
Etodolac—Myalgia—Doxorubicin—pancreatic cancer	9.43e-05	0.000439	CcSEcCtD
Etodolac—Anxiety—Doxorubicin—pancreatic cancer	9.4e-05	0.000437	CcSEcCtD
Etodolac—Discomfort—Doxorubicin—pancreatic cancer	9.32e-05	0.000434	CcSEcCtD
Etodolac—Anorexia—Epirubicin—pancreatic cancer	9.31e-05	0.000433	CcSEcCtD
Etodolac—Dry mouth—Doxorubicin—pancreatic cancer	9.22e-05	0.000429	CcSEcCtD
Etodolac—Vomiting—Docetaxel—pancreatic cancer	9.21e-05	0.000429	CcSEcCtD
Etodolac—Rash—Docetaxel—pancreatic cancer	9.13e-05	0.000425	CcSEcCtD
Etodolac—Hypotension—Epirubicin—pancreatic cancer	9.13e-05	0.000425	CcSEcCtD
Etodolac—Dermatitis—Docetaxel—pancreatic cancer	9.13e-05	0.000425	CcSEcCtD
Etodolac—Confusional state—Doxorubicin—pancreatic cancer	9.12e-05	0.000424	CcSEcCtD
Etodolac—Headache—Docetaxel—pancreatic cancer	9.08e-05	0.000422	CcSEcCtD
Etodolac—Anaphylactic shock—Doxorubicin—pancreatic cancer	9.04e-05	0.000421	CcSEcCtD
Etodolac—Oedema—Doxorubicin—pancreatic cancer	9.04e-05	0.000421	CcSEcCtD
Etodolac—Infection—Doxorubicin—pancreatic cancer	8.98e-05	0.000418	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.9e-05	0.000414	CcSEcCtD
Etodolac—Shock—Doxorubicin—pancreatic cancer	8.9e-05	0.000414	CcSEcCtD
Etodolac—Thrombocytopenia—Doxorubicin—pancreatic cancer	8.85e-05	0.000412	CcSEcCtD
Etodolac—Insomnia—Epirubicin—pancreatic cancer	8.84e-05	0.000411	CcSEcCtD
Etodolac—Tachycardia—Doxorubicin—pancreatic cancer	8.82e-05	0.000411	CcSEcCtD
Etodolac—Paraesthesia—Epirubicin—pancreatic cancer	8.77e-05	0.000408	CcSEcCtD
Etodolac—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.74e-05	0.000407	CcSEcCtD
Etodolac—Dyspnoea—Epirubicin—pancreatic cancer	8.71e-05	0.000405	CcSEcCtD
Etodolac—Somnolence—Epirubicin—pancreatic cancer	8.69e-05	0.000404	CcSEcCtD
Etodolac—Anorexia—Doxorubicin—pancreatic cancer	8.62e-05	0.000401	CcSEcCtD
Etodolac—Nausea—Docetaxel—pancreatic cancer	8.61e-05	0.0004	CcSEcCtD
Etodolac—Dyspepsia—Epirubicin—pancreatic cancer	8.6e-05	0.0004	CcSEcCtD
Etodolac—Decreased appetite—Epirubicin—pancreatic cancer	8.49e-05	0.000395	CcSEcCtD
Etodolac—Hypotension—Doxorubicin—pancreatic cancer	8.45e-05	0.000393	CcSEcCtD
Etodolac—Fatigue—Epirubicin—pancreatic cancer	8.42e-05	0.000392	CcSEcCtD
Etodolac—Pain—Epirubicin—pancreatic cancer	8.36e-05	0.000389	CcSEcCtD
Etodolac—Constipation—Epirubicin—pancreatic cancer	8.36e-05	0.000389	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.24e-05	0.000383	CcSEcCtD
Etodolac—Insomnia—Doxorubicin—pancreatic cancer	8.18e-05	0.00038	CcSEcCtD
Etodolac—Paraesthesia—Doxorubicin—pancreatic cancer	8.12e-05	0.000378	CcSEcCtD
Etodolac—Dyspnoea—Doxorubicin—pancreatic cancer	8.06e-05	0.000375	CcSEcCtD
Etodolac—Feeling abnormal—Epirubicin—pancreatic cancer	8.05e-05	0.000375	CcSEcCtD
Etodolac—Somnolence—Doxorubicin—pancreatic cancer	8.04e-05	0.000374	CcSEcCtD
Etodolac—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.99e-05	0.000372	CcSEcCtD
Etodolac—Dyspepsia—Doxorubicin—pancreatic cancer	7.96e-05	0.00037	CcSEcCtD
Etodolac—Decreased appetite—Doxorubicin—pancreatic cancer	7.86e-05	0.000366	CcSEcCtD
Etodolac—Fatigue—Doxorubicin—pancreatic cancer	7.79e-05	0.000363	CcSEcCtD
Etodolac—Urticaria—Epirubicin—pancreatic cancer	7.76e-05	0.000361	CcSEcCtD
Etodolac—Pain—Doxorubicin—pancreatic cancer	7.73e-05	0.00036	CcSEcCtD
Etodolac—Constipation—Doxorubicin—pancreatic cancer	7.73e-05	0.00036	CcSEcCtD
Etodolac—Body temperature increased—Epirubicin—pancreatic cancer	7.72e-05	0.000359	CcSEcCtD
Etodolac—Abdominal pain—Epirubicin—pancreatic cancer	7.72e-05	0.000359	CcSEcCtD
Etodolac—Feeling abnormal—Doxorubicin—pancreatic cancer	7.45e-05	0.000347	CcSEcCtD
Etodolac—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.39e-05	0.000344	CcSEcCtD
Etodolac—Hypersensitivity—Epirubicin—pancreatic cancer	7.2e-05	0.000335	CcSEcCtD
Etodolac—Urticaria—Doxorubicin—pancreatic cancer	7.18e-05	0.000334	CcSEcCtD
Etodolac—Abdominal pain—Doxorubicin—pancreatic cancer	7.15e-05	0.000333	CcSEcCtD
Etodolac—Body temperature increased—Doxorubicin—pancreatic cancer	7.15e-05	0.000333	CcSEcCtD
Etodolac—Asthenia—Epirubicin—pancreatic cancer	7.01e-05	0.000326	CcSEcCtD
Etodolac—Pruritus—Epirubicin—pancreatic cancer	6.91e-05	0.000322	CcSEcCtD
Etodolac—Diarrhoea—Epirubicin—pancreatic cancer	6.69e-05	0.000311	CcSEcCtD
Etodolac—Hypersensitivity—Doxorubicin—pancreatic cancer	6.66e-05	0.00031	CcSEcCtD
Etodolac—Asthenia—Doxorubicin—pancreatic cancer	6.49e-05	0.000302	CcSEcCtD
Etodolac—Dizziness—Epirubicin—pancreatic cancer	6.46e-05	0.000301	CcSEcCtD
Etodolac—Pruritus—Doxorubicin—pancreatic cancer	6.4e-05	0.000298	CcSEcCtD
Etodolac—Vomiting—Epirubicin—pancreatic cancer	6.21e-05	0.000289	CcSEcCtD
Etodolac—Diarrhoea—Doxorubicin—pancreatic cancer	6.19e-05	0.000288	CcSEcCtD
Etodolac—Rash—Epirubicin—pancreatic cancer	6.16e-05	0.000287	CcSEcCtD
Etodolac—Dermatitis—Epirubicin—pancreatic cancer	6.16e-05	0.000286	CcSEcCtD
Etodolac—Headache—Epirubicin—pancreatic cancer	6.12e-05	0.000285	CcSEcCtD
Etodolac—Dizziness—Doxorubicin—pancreatic cancer	5.98e-05	0.000278	CcSEcCtD
Etodolac—Nausea—Epirubicin—pancreatic cancer	5.8e-05	0.00027	CcSEcCtD
Etodolac—Vomiting—Doxorubicin—pancreatic cancer	5.75e-05	0.000267	CcSEcCtD
Etodolac—Rash—Doxorubicin—pancreatic cancer	5.7e-05	0.000265	CcSEcCtD
Etodolac—Dermatitis—Doxorubicin—pancreatic cancer	5.7e-05	0.000265	CcSEcCtD
Etodolac—Headache—Doxorubicin—pancreatic cancer	5.66e-05	0.000264	CcSEcCtD
Etodolac—Nausea—Doxorubicin—pancreatic cancer	5.37e-05	0.00025	CcSEcCtD
Etodolac—ALB—Hemostasis—CD44—pancreatic cancer	2.59e-05	0.000626	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SLC2A2—pancreatic cancer	2.59e-05	0.000626	CbGpPWpGaD
Etodolac—PTGS2—Disease—PPP2R5B—pancreatic cancer	2.59e-05	0.000625	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.59e-05	0.000625	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.56e-05	0.00062	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ARG2—pancreatic cancer	2.55e-05	0.000616	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	2.51e-05	0.000608	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IFNA1—pancreatic cancer	2.51e-05	0.000606	CbGpPWpGaD
Etodolac—PTGS2—Disease—HEY2—pancreatic cancer	2.49e-05	0.000602	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.47e-05	0.000598	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CD44—pancreatic cancer	2.47e-05	0.000597	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.44e-05	0.00059	CbGpPWpGaD
Etodolac—ALB—Metabolism—PRSS1—pancreatic cancer	2.38e-05	0.000575	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.38e-05	0.000574	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GCG—pancreatic cancer	2.37e-05	0.000572	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SMAD4—pancreatic cancer	2.34e-05	0.000565	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IFNA2—pancreatic cancer	2.33e-05	0.000564	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.32e-05	0.00056	CbGpPWpGaD
Etodolac—PTGS2—Disease—HEY1—pancreatic cancer	2.31e-05	0.000557	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CD44—pancreatic cancer	2.3e-05	0.000557	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GLP1R—pancreatic cancer	2.26e-05	0.000547	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.25e-05	0.000545	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.25e-05	0.000545	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—TYMS—pancreatic cancer	2.25e-05	0.000544	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—CTNNB1—pancreatic cancer	2.24e-05	0.000541	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.23e-05	0.00054	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TYMP—pancreatic cancer	2.23e-05	0.000538	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—STK11—pancreatic cancer	2.22e-05	0.000538	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—DPYD—pancreatic cancer	2.22e-05	0.000538	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GCG—pancreatic cancer	2.21e-05	0.000534	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MMP9—pancreatic cancer	2.19e-05	0.00053	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	2.19e-05	0.00053	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.19e-05	0.000528	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.18e-05	0.000527	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.14e-05	0.000517	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC2A2—pancreatic cancer	2.11e-05	0.00051	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.09e-05	0.000505	CbGpPWpGaD
Etodolac—RXRA—Metabolism—STK11—pancreatic cancer	2.08e-05	0.000502	CbGpPWpGaD
Etodolac—ALB—Metabolism—ARG2—pancreatic cancer	2.06e-05	0.000498	CbGpPWpGaD
Etodolac—PTGS2—Disease—JAG2—pancreatic cancer	2.04e-05	0.000494	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.04e-05	0.000492	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—SRC—pancreatic cancer	2.02e-05	0.000489	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.02e-05	0.000488	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.02e-05	0.000488	CbGpPWpGaD
Etodolac—PTGS2—Disease—MEN1—pancreatic cancer	2.02e-05	0.000487	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CD44—pancreatic cancer	2.01e-05	0.000485	CbGpPWpGaD
Etodolac—PTGS2—Disease—SLC2A2—pancreatic cancer	2e-05	0.000484	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—pancreatic cancer	1.97e-05	0.000476	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.96e-05	0.000475	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—STAT3—pancreatic cancer	1.95e-05	0.000472	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.95e-05	0.000471	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.95e-05	0.000471	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—NRAS—pancreatic cancer	1.95e-05	0.000471	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.95e-05	0.00047	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—MYC—pancreatic cancer	1.93e-05	0.000466	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GCG—pancreatic cancer	1.92e-05	0.000465	CbGpPWpGaD
Etodolac—PTGS2—Disease—SHH—pancreatic cancer	1.92e-05	0.000465	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—TYMS—pancreatic cancer	1.91e-05	0.000463	CbGpPWpGaD
Etodolac—PTGS2—Disease—IAPP—pancreatic cancer	1.9e-05	0.000459	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.86e-05	0.000449	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.84e-05	0.000444	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.84e-05	0.000444	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—APOE—pancreatic cancer	1.83e-05	0.000443	CbGpPWpGaD
Etodolac—PTGS2—Disease—HSPA1B—pancreatic cancer	1.82e-05	0.000441	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TGFB1—pancreatic cancer	1.81e-05	0.000437	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—STK11—pancreatic cancer	1.81e-05	0.000437	CbGpPWpGaD
Etodolac—ALB—Metabolism—TYMP—pancreatic cancer	1.8e-05	0.000436	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GLP1R—pancreatic cancer	1.8e-05	0.000434	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.79e-05	0.000434	CbGpPWpGaD
Etodolac—RXRA—Metabolism—TYMS—pancreatic cancer	1.79e-05	0.000432	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—EGFR—pancreatic cancer	1.77e-05	0.000429	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—DPYD—pancreatic cancer	1.77e-05	0.000427	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	1.76e-05	0.000425	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—NOTCH1—pancreatic cancer	1.72e-05	0.000417	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	1.71e-05	0.000413	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.7e-05	0.00041	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—pancreatic cancer	1.69e-05	0.000408	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.69e-05	0.000408	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC2A2—pancreatic cancer	1.68e-05	0.000405	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—KRAS—pancreatic cancer	1.67e-05	0.000405	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.66e-05	0.000401	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PLAU—pancreatic cancer	1.66e-05	0.000401	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CG—pancreatic cancer	1.65e-05	0.000399	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CD44—pancreatic cancer	1.63e-05	0.000395	CbGpPWpGaD
Etodolac—PTGS2—Disease—JAG1—pancreatic cancer	1.63e-05	0.000394	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PPARG—pancreatic cancer	1.63e-05	0.000393	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.6e-05	0.000387	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.6e-05	0.000387	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PPARG—pancreatic cancer	1.59e-05	0.000385	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.59e-05	0.000384	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	1.57e-05	0.00038	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GCG—pancreatic cancer	1.57e-05	0.000379	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—APOE—pancreatic cancer	1.56e-05	0.000376	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—TYMS—pancreatic cancer	1.56e-05	0.000376	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD44—pancreatic cancer	1.55e-05	0.000375	CbGpPWpGaD
Etodolac—PTGS2—Disease—HSPA1A—pancreatic cancer	1.54e-05	0.000372	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.52e-05	0.000366	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.49e-05	0.000359	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.47e-05	0.000357	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CG—pancreatic cancer	1.47e-05	0.000356	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—STK11—pancreatic cancer	1.47e-05	0.000356	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.46e-05	0.000353	CbGpPWpGaD
Etodolac—ALB—Hemostasis—EGF—pancreatic cancer	1.46e-05	0.000352	CbGpPWpGaD
Etodolac—ALB—Metabolism—GLP1R—pancreatic cancer	1.45e-05	0.000351	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CD—pancreatic cancer	1.45e-05	0.000351	CbGpPWpGaD
Etodolac—RXRA—Metabolism—APOE—pancreatic cancer	1.45e-05	0.000351	CbGpPWpGaD
Etodolac—ALB—Metabolism—DPYD—pancreatic cancer	1.43e-05	0.000345	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—HRAS—pancreatic cancer	1.42e-05	0.000344	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CG—pancreatic cancer	1.4e-05	0.00034	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.38e-05	0.000334	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.37e-05	0.000332	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC2A2—pancreatic cancer	1.36e-05	0.000328	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PPARG—pancreatic cancer	1.36e-05	0.000328	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.34e-05	0.000324	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	1.34e-05	0.000323	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CG—pancreatic cancer	1.31e-05	0.000317	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CD44—pancreatic cancer	1.3e-05	0.000314	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CD—pancreatic cancer	1.3e-05	0.000313	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.3e-05	0.000313	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.27e-05	0.000307	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—TYMS—pancreatic cancer	1.27e-05	0.000307	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CB—pancreatic cancer	1.27e-05	0.000306	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—APOE—pancreatic cancer	1.26e-05	0.000306	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PPARG—pancreatic cancer	1.26e-05	0.000306	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—AKT1—pancreatic cancer	1.26e-05	0.000304	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—pancreatic cancer	1.25e-05	0.000303	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GCG—pancreatic cancer	1.24e-05	0.000301	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CD—pancreatic cancer	1.23e-05	0.000299	CbGpPWpGaD
Etodolac—PTGS2—Disease—SMAD4—pancreatic cancer	1.22e-05	0.000296	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.22e-05	0.000294	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.2e-05	0.000289	CbGpPWpGaD
Etodolac—PTGS2—Disease—HES1—pancreatic cancer	1.19e-05	0.000289	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.19e-05	0.000287	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.18e-05	0.000285	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—STK11—pancreatic cancer	1.17e-05	0.000283	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.17e-05	0.000283	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CD—pancreatic cancer	1.15e-05	0.000278	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CG—pancreatic cancer	1.14e-05	0.000276	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CB—pancreatic cancer	1.13e-05	0.000273	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.11e-05	0.000268	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PPARG—pancreatic cancer	1.1e-05	0.000266	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.1e-05	0.000266	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.1e-05	0.000266	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTEN—pancreatic cancer	1.09e-05	0.000264	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.09e-05	0.000264	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	1.08e-05	0.00026	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—pancreatic cancer	1.07e-05	0.000258	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.06e-05	0.000256	CbGpPWpGaD
Etodolac—ALB—Metabolism—CD44—pancreatic cancer	1.05e-05	0.000254	CbGpPWpGaD
Etodolac—PTGS2—Disease—TERT—pancreatic cancer	1.05e-05	0.000253	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—APOE—pancreatic cancer	1.03e-05	0.000249	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.03e-05	0.000249	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.02e-05	0.000246	CbGpPWpGaD
Etodolac—ALB—Metabolism—GCG—pancreatic cancer	1.01e-05	0.000243	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TYMS—pancreatic cancer	1.01e-05	0.000243	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CB—pancreatic cancer	1e-05	0.000243	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CD—pancreatic cancer	1e-05	0.000243	CbGpPWpGaD
Etodolac—PTGS2—Disease—HIF1A—pancreatic cancer	1e-05	0.000242	CbGpPWpGaD
Etodolac—PTGS2—Disease—TSC2—pancreatic cancer	9.99e-06	0.000241	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—pancreatic cancer	9.95e-06	0.000241	CbGpPWpGaD
Etodolac—PTGS2—Disease—APOE—pancreatic cancer	9.77e-06	0.000236	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.76e-06	0.000236	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.66e-06	0.000233	CbGpPWpGaD
Etodolac—ALB—Metabolism—STK11—pancreatic cancer	9.47e-06	0.000229	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CG—pancreatic cancer	9.3e-06	0.000225	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTEN—pancreatic cancer	9.3e-06	0.000225	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—pancreatic cancer	9.27e-06	0.000224	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SRC—pancreatic cancer	9.05e-06	0.000219	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOTCH1—pancreatic cancer	9.02e-06	0.000218	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PPARG—pancreatic cancer	8.98e-06	0.000217	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.88e-06	0.000215	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—pancreatic cancer	8.81e-06	0.000213	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CB—pancreatic cancer	8.75e-06	0.000211	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGF—pancreatic cancer	8.72e-06	0.000211	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NRAS—pancreatic cancer	8.71e-06	0.000211	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTEN—pancreatic cancer	8.68e-06	0.00021	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—pancreatic cancer	8.67e-06	0.00021	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CD44—pancreatic cancer	8.59e-06	0.000208	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.42e-06	0.000203	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.34e-06	0.000202	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GCG—pancreatic cancer	8.24e-06	0.000199	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APOE—pancreatic cancer	8.18e-06	0.000198	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CD—pancreatic cancer	8.18e-06	0.000198	CbGpPWpGaD
Etodolac—ALB—Metabolism—TYMS—pancreatic cancer	8.14e-06	0.000197	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TGFB1—pancreatic cancer	8.09e-06	0.000196	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CD—pancreatic cancer	7.75e-06	0.000187	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—STK11—pancreatic cancer	7.75e-06	0.000187	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.75e-06	0.000187	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CA—pancreatic cancer	7.72e-06	0.000187	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTEN—pancreatic cancer	7.56e-06	0.000183	CbGpPWpGaD
Etodolac—ALB—Hemostasis—KRAS—pancreatic cancer	7.49e-06	0.000181	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CG—pancreatic cancer	7.39e-06	0.000179	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.27e-06	0.000176	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CB—pancreatic cancer	7.13e-06	0.000172	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PPARG—pancreatic cancer	7.13e-06	0.000172	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—pancreatic cancer	7.06e-06	0.000171	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CA—pancreatic cancer	6.88e-06	0.000166	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CB—pancreatic cancer	6.76e-06	0.000163	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TYMS—pancreatic cancer	6.66e-06	0.000161	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—pancreatic cancer	6.66e-06	0.000161	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOE—pancreatic cancer	6.62e-06	0.00016	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	6.56e-06	0.000159	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CD—pancreatic cancer	6.49e-06	0.000157	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—AKT1—pancreatic cancer	6.43e-06	0.000155	CbGpPWpGaD
Etodolac—ALB—Hemostasis—HRAS—pancreatic cancer	6.37e-06	0.000154	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKT1—pancreatic cancer	6.3e-06	0.000152	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.27e-06	0.000152	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTEN—pancreatic cancer	6.16e-06	0.000149	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CA—pancreatic cancer	6.12e-06	0.000148	CbGpPWpGaD
Etodolac—PTGS2—Disease—CTNNB1—pancreatic cancer	5.99e-06	0.000145	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CG—pancreatic cancer	5.98e-06	0.000144	CbGpPWpGaD
Etodolac—PTGS2—Disease—PTEN—pancreatic cancer	5.84e-06	0.000141	CbGpPWpGaD
Etodolac—ALB—Metabolism—PPARG—pancreatic cancer	5.77e-06	0.000139	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CB—pancreatic cancer	5.66e-06	0.000137	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT1—pancreatic cancer	5.62e-06	0.000136	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOE—pancreatic cancer	5.42e-06	0.000131	CbGpPWpGaD
Etodolac—PTGS2—Disease—SRC—pancreatic cancer	5.42e-06	0.000131	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKT1—pancreatic cancer	5.36e-06	0.00013	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CA—pancreatic cancer	5.33e-06	0.000129	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CD—pancreatic cancer	5.25e-06	0.000127	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—pancreatic cancer	5.22e-06	0.000126	CbGpPWpGaD
Etodolac—PTGS2—Disease—NRAS—pancreatic cancer	5.21e-06	0.000126	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.13e-06	0.000124	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKT1—pancreatic cancer	5e-06	0.000121	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	4.89e-06	0.000118	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTEN—pancreatic cancer	4.89e-06	0.000118	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—pancreatic cancer	4.85e-06	0.000117	CbGpPWpGaD
Etodolac—PTGS2—Disease—TGFB1—pancreatic cancer	4.84e-06	0.000117	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGFR—pancreatic cancer	4.75e-06	0.000115	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPARG—pancreatic cancer	4.72e-06	0.000114	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CB—pancreatic cancer	4.58e-06	0.000111	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—pancreatic cancer	4.54e-06	0.00011	CbGpPWpGaD
Etodolac—PTGS2—Disease—KRAS—pancreatic cancer	4.48e-06	0.000108	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKT1—pancreatic cancer	4.36e-06	0.000105	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CA—pancreatic cancer	4.35e-06	0.000105	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	4.3e-06	0.000104	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CA—pancreatic cancer	4.12e-06	9.96e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTEN—pancreatic cancer	3.96e-06	9.57e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HRAS—pancreatic cancer	3.81e-06	9.22e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.75e-06	9.06e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.71e-06	8.98e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKT1—pancreatic cancer	3.55e-06	8.58e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CA—pancreatic cancer	3.45e-06	8.34e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT1—pancreatic cancer	3.37e-06	8.14e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTEN—pancreatic cancer	3.24e-06	7.83e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKT1—pancreatic cancer	2.82e-06	6.81e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CA—pancreatic cancer	2.79e-06	6.75e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.28e-06	5.52e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKT1—pancreatic cancer	2.28e-06	5.51e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.87e-06	4.51e-05	CbGpPWpGaD
